TSRI scientists design potential drug candidate to treat triple negative breast cance

[News]

In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.

More... (http://www.news-medical.net/news/20160510/TSRI-scientists-design-potential-drug-candidate-to-treat-triple-negative-breast-cancer.aspx)